Canadian Urological Association (CUA): Recent Episodes
Canadian Urological Association / L'Association des urologues du Canada
The official podcast of the Canadian Urological Association (CUA). Le podcast officiel de l'association des urologues du Canada (AUC).
Episode NotesPodcast Host Disclosures:
Dr. Choueiri reports institutional and/or personal, paid and/or unpaid support for research, advisory boards, consultancy, and/or honoraria from: Alkermes, AstraZeneca, Aravive, Aveo, Bayer, Bristol Myers-Squibb, Calithera, Circle Pharma, Eisai, EMD Serono, Exelixis, GlaxoSmithKline, Gilead, IQVA, Infinity, Ipsen, Jansen, Kanaph, Lilly, Merck, Nikang, Nuscan, Novartis, Oncohost, Pfizer, Roche, Sanofi/Aventis, Scholar Rock, Surface Oncology, Takeda, Tempest, Up-To-Date, CME events (Peerview, OncLive, MJH, CCO and others), outside the submitted work. Institutional patents filed on molecular alterations and immunotherapy response/toxicity, and ctDNA. Equity: Tempest, Pionyr, Osel, Precede Bio, CureResponse, InnDura. Committees: NCCN, GU Steering Committee, ASCO/ESMO, ACCRU, KidneyCan. Medical writing and editorial assistance support may have been funded by Communications companies in part. No speaker’s bureau. Mentored several non-US citizens on research projects with potential funding (in part) from non-US sources/Foreign Components. The institution (Dana-Farber Cancer Institute) may have received additional independent funding of drug companies or/and royalties potentially involved in research around the subject matter. T. K. Choueiri is supported in part by the Dana-Farber/Harvard Cancer Center Kidney SPORE (2P50CA101942-16) and Program 5P30CA006516-56, the Kohlberg Chair at Harvard Medical School and the Trust Family, Michael Brigham, Pan Mass Challenge, Hinda and Arthur Marcus Fund and Loker Pinard Funds for Kidney Cancer Research at DFCI.
Dr. Lalani has received honoraria from AbbVie, Astellas, AstraZeneca, Bayer, BMS, Eisai, EMD Serono, Ipsen, Janssen, McKesson, Merck, Novartis, Pfizer, Roche, TerSera. Funding for clinical trials directed to institutions from BMS (Inst), BioCanRx (Inst), Novartis (Inst), Roche (Inst), Ipsen (Inst), EMD Serrono (Inst).
Accreditation:
This podcast was accredited by the Canadian Urological Association in accordance with the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
After completing the self-assessment questions at the link below, listeners are eligible to claim Section 3 self-assessment credits.
Obtain Section 3 Credits Here >
The fourth episode of the 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz. This episode features an introductory discussion on bladder cancer.
Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.com
References from the show:
Bladder Cancer Canada
Disclaimer: The information provided in this podcast is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
The third episode of the 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz. This episode features a discussion on urinary tract infections in women.
Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.com
Disclaimer: The information provided in this podcast is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
The second episode of the 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz. This episode features a discussion on male voiding disorders and Benign Prostatic Hyperplasia (BPH).
Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.com
References from the show:
CUA BPH Guidelines - Google Search
Welcome to Canadian Urological Association | Canadian Urological Association (cua.org)
Disclaimer: The information provided in this podcast is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Our inaugural 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz! This first podcast in the series focuses on PSA and Prostate Cancer Screening.
Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.com
References from the show:
UPDATE – 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis - PMC (nih.gov)
UBC & VGH Centre of Excellence | Vancouver Prostate Centre
Welcome to Canadian Urological Association | Canadian Urological Association (cua.org)
Disclaimer: The information provided in this podcast is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Program Chair: Ricardo Rendon
Kidney Cancer Panelists: Melissa Huynh, Lori Wood
Sponsors:
Gold: Bristol Myers Squibb, Merck
Silver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen
Program Chair: Ricardo Rendon
Kidney Cancer Panelists: Melissa Huynh, Lori Wood
Sponsors:
Gold: Bristol Myers Squibb, Merck
Silver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen
Program Chair: Ricardo Rendon
Bladder Cancer Panelists: Peter Black, Maria Jiang
Sponsors:
Gold: Bristol Myers Squibb, Merck
Silver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen
Program Chair: Ricardo Rendon
Bladder Cancer Panelists: Peter Black, Maria Jiang
Sponsors:
Gold: Bristol Myers Squibb, Merck
Silver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen
Program Chair: Ricardo Rendon
Prostate Cancer Panelists: Ricardo Rendon, Sebastien Hotte, Scott Morgan
Sponsors:
Gold: Bristol Myers Squibb, Merck
Silver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen
Program Chair: Ricardo Rendon
Prostate Cancer Panelists: Ricardo Rendon, Sebastien Hotte, Scott Morgan
Sponsors:
Gold: Bristol Myers Squibb, Merck
Silver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen
Jean Gregoire, MD, FRCP(C), FCCS, FACC, FACP
University of Montreal
Institut de cardiologie de Montreal
Jean Gregoire, MD, FRCP(C), FCCS, FACC, FACP
University of Montreal
Institut de cardiologie de Montreal
Sponsored by Amgen.
Luke Lavallee
Urologic Oncologist and Associate Scientist
The Ottawa Hospital
Ottawa Hospital Research Institute
Disclosures:
Advisory Board: Sanofi, Ferring, Knight, Bayer, Janssen, Astellas
Grant/Honorarium: Sanofi
Sponsored by Amgen.
Sophie Mottard
Orthopedic Oncology Surgeon
Maisonneuve-Rosemont Hospital
CHU Saint-Justine and Santa Cabrini Hospital
Disclosures:
Payment: Amgen (conference speaker)
Sponsored by Amgen.
David Kendler
Endocrinologist and Clinical Professor
UBC
Disclosures:
Advisory Board: Amgen, Paladin, Biosynt
Speakers Bureau: Amgen
Payment: Amgen, Biosynt, Radius Pharma, Paladin
Grant/Honorarium: Amgen, Biosynt, Radius Pharma, Paladin
Clinical Trial: Radius Pharma
Leadership/Board Position: Specialists of BC, Drs. of BC section of Endocrinology (executive)
Disclosures:
Hassan Razvi
Patent: Cook Urological
Clinical Trials: Boston Scientific, Verity Pharma
Leadership/board position: AUA, Endourology Society
Olivier Traxer
Consultant: Karl Storz, Coloplast, IPG Medical, ROCAMED, Boston Scientific, Quanta, AMBU
Disclosures:
Hassan Razvi
Patent: Cook Urological
Clinical Trials: Boston Scientific, Verity Pharma
Leadership/board position: AUA, Endourology Society
Olivier Traxer
Consultant: Karl Storz, Coloplast, IPG Medical, ROCAMED, Boston Scientific, Quanta, AMBU
Disclosures:
Anil Kapoor
Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca
Speakers Bureau: Merck, Ipsen, Eisai
Investments: Verity, Point Biopharma
Clinical Trials: CCTG, Eisai, Janssen, Merck
Leadership/Board Position
Christian Kollmannsberger
Consultant: Pfizer, Merck, Sanofi, Astellas, BMS, Ipsen, Eisai, Bayer
Honoraria for presentations: Pfizer, Ipsen, Eisai, BMS, Janssen, Bayer
Scientific Advisory Board: Pfizer, Novartis, Ipsen, Eisai, Sanofi, Astellas, BMS, Janssen, Bayer, Merck
Disclosures:
Anil Kapoor
Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca
Speakers Bureau: Merck, Ipsen, Eisai
Investments: Verity, Point Biopharma
Clinical Trials: CCTG, Eisai, Janssen, Merck
Leadership/Board Position
Nimira Alimohamed
Advisory Board/Consultancy roles: Pfizer, EMD Serono, Merck, Seagen
Wassim Kassouf
No disclosures
Alejandro Berlin
No disclosures
Disclosures:
Anil Kapoor
Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca
Speakers Bureau: Merck, Ipsen, Eisai
Investments: Verity, Point Biopharma
Clinical Trials: CCTG, Eisai, Janssen, Merck
Leadership/Board Position
Tamim Niazi
Honoraria/ research funding: Abbvie, Astellas, Bayer, Janssen, Sanofi, Merck, AstraZeneca, TerSera, Knight Therapeutics, Amgen, Tolmar, Sanofi, Ferring
Krista Noonan
Consultancy-Astellas, AstraZeneca, EMD Serono, Janssen, Pfizer
Ricardo Rendon
Advisory Board: Astellas, Amgen, Abbvie, AstraZeneca, Bayer, Ferring, Janssen, Sanofi, TerSera
Speakers' Bureau: Amgen, Astellas, Bayer, Ferring, Janssen,
Grant/Honorarium: Astellas, Amgen, Bayer Janssen
Clinical Trial: Abbvie, Amgen, Astellas, AstraZeneca, Ferring, Janssen, Pfizer, Sanofi, Myovant
Disclosures:
Anil Kapoor
Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca
Speakers Bureau: Merck, Ipsen, Eisai
Investments: Verity, Point Biopharma
Clinical Trials: CCTG, Eisai, Janssen, Merck
Leadership/Board Position
Nimira Alimohamed
Advisory Board/Consultancy roles: Pfizer, EMD Serono, Merck, Seagen
Wassim Kassouf
No disclosures
Alejandro Berlin
No disclosures
Disclosures:
Anil Kapoor
Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca
Speakers Bureau: Merck, Ipsen, Eisai
Investments: Verity, Point Biopharma
Clinical Trials: CCTG, Eisai, Janssen, Merck
Leadership/Board Position
Tamim Niazi
Honoraria/ research funding: Abbvie, Astellas, Bayer, Janssen, Sanofi, Merck, AstraZeneca, TerSera, Knight Therapeutics, Amgen, Tolmar, Sanofi, Ferring
Krista Noonan
Consultancy-Astellas, AstraZeneca, EMD Serono, Janssen, Pfizer
Ricardo Rendon
Advisory Board: Astellas, Amgen, Abbvie, AstraZeneca, Bayer, Ferring, Janssen, Sanofi, TerSera
Speakers' Bureau: Amgen, Astellas, Bayer, Ferring, Janssen,
Grant/Honorarium: Astellas, Amgen, Bayer Janssen
Clinical Trial: Abbvie, Amgen, Astellas, AstraZeneca, Ferring, Janssen, Pfizer, Sanofi, Myovant
Disclosures:
Anil Kapoor
Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca
Speakers Bureau: Merck, Ipsen, Eisai
Investments: Verity, Point Biopharma
Clinical Trials: CCTG, Eisai, Janssen, Merck
Leadership/Board Position
Christian Kollmannsberger
Consultant: Pfizer, Merck, Sanofi, Astellas, BMS, Ipsen, Eisai, Bayer
Honoraria for presentations: Pfizer, Ipsen, Eisai, BMS, Janssen, Bayer
Scientific Advisory Board: Pfizer, Novartis, Ipsen, Eisai, Sanofi, Astellas, BMS, Janssen, Bayer, Merck
Disclosures:
Dean Elterman
Advisory Boards/ Speakers Bureaus: Astellas, Boston Scientific, Duchesnay, Pfizer, Procept, Prodeon, Olympus, Medtronic, Urotronic, Zeneflow
Kevin Zorn
Advisory Board: BSCI, Procept, Zenflow
Disclosures:
Fred Saad
Grants/Honoraria: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, Sanofi
Eleni Efstathiou
Research Support/P.I.: Janssen, Sanofi-Genzyme, Astellas/Medivation, Oric-Pharma, Nuvation
Scientific Advisory Board/Honoraria: Janssen, Sanofi-Genzyme, Bayer, Oric Pharma, Marck, AAA-Novartis, Genetech, Astra-Zeneca, Astellas, Pfizer, Myovant
Disclosures:
Fred Saad
Grants/Honoraria: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, Sanofi
Eleni Efstathiou
Research Support/P.I.: Janssen, Sanofi-Genzyme, Astellas/Medivation, Oric-Pharma, Nuvation
Scientific Advisory Board/Honoraria: Janssen, Sanofi-Genzyme, Bayer, Oric Pharma, Marck, AAA-Novartis, Genetech, Astra-Zeneca, Astellas, Pfizer, Myovant
Disclosures:
Anil Kapoor
Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca
Speakers Bureau: Merck, Ipsen, Eisai
Investments: Verity, Point Biopharma
Clinical Trials: CCTG, Eisai, Janssen, Merck
Leadership/Board Position: Kidney Cancer Canada
Luke Lavallee
Advisory Board: Sanofi, Ferring, Knight, Bayer, Janssen, Astellas
Grant/Honorarium: Sanofi
Disclosures:
Derek Henderson
Banking relationship with TD
Christopher French
Advisory Boards: Astellas, AstraZeneca
Disclosures:
Martine Jolivet
Advisory Board and/or Speaker Bureau: Allergan/Abbvie
Genevieve Nadeau
Clinical Trials: Contiform International
Advisory Board and/or Speaker Bureau: Pfizer, Boston Scientific, Astellas, Allergan/Abbvie, Searchlight Pharma
Disclosures:
Kevin Carlson
Advisory Board/Payment: Abbvie
Richard Baverstock
Advisory Board: Abbvie
Speakers Bureau: Astellas, Boston Scientific, Abbvie
Payment: Abbvie, Astellas, Bsci
Greg Baily
Advisory Board/ Speaker Bureau: Abbvie
Disclosures:
Kevin Carlson
Advisroy Board/Payment: Abbvie
Richard Baverstock
Advisory Board: Abbvie
Speakers Bureau: Astellas, Boston Scientific, Abbvie
Payment: Abbvie, Astellas, Bsci
Greg Baily
Advisory Board/ Speaker Bureau: Abbvie
Disclosures:
Neil Fleshner
Payment: Astellas, Janssen, Abbvie, Sanofi, Merck
Grant/Honorarium: Astellas, Janssen, Bayer
Investments: Verity Pharma
Clinical Trials: Astellas, Janssen, Bayer
Leadership Position: Point Biopharma
Urban Emmenegger
Advisory Boards: Amgen, Astellas, Bayer, Ferring, Janssen, Sanofi, Merck, AstraZeneca
Payment: Astellas, Bayer, Ferring, Janssen, Sanofi, Merck, AstraZeneca
Grant/Honorarium: Amgen, Astellas, Bayer, Ferring, Janssen, Sanofi, Merck, AstraZeneca
Clinical Trials: AstraZeneca, Bayer, Clovis, Janssen, Merck, Roche
Emily Thain
Advisory Boards: AstraZeneca/Merck, Pfizer
Honorarium: AstraZeneca/Merck, Pfizer
Conflits d'interests:
Fred Saad
Subventions/honoraires: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, Sanofi
Zineb Hamilou
Remuneration: AstraZeneca, Sengen, EMD Serono
Essai Clinique: Sengen
Evan Weber
Subventions ou des honoraires: AstraZeneca/Merck
Disclosures:
Ashley Cox
Advisory Board: Abbvie, Allergan
Rachel S. Rubin
Speakers Bureau: Sprout
Clinical Trials: Ipsen, Abbvie
Leadership/Board Position: ISSWSH
Disclosures:
Ashley Cox
Advisory Board: Abbvie, Allergan
Rachel S. Rubin
Speakers Bureau: Sprout
Clinical Trials: Ipsen, Abbvie
Leadership/Board Position: ISSWSH
Disclosures:
Armin Aprikian
Advisory boards: Abbvie, Astellas, Bayer
Grant/Honorarium: Abbvie, Astellas, Bayer, Sanofi, TerSera
Robert Hamilton
Advisory boards: Janssen, Astellas, Bayer, TerSera
Clinical Trials: Janssen, Bayer, Astellas
Disclosures:
Armand Zini
Shareholder in YAD Tech - a neutraceuticals company
Jesse Ory
No disclosures
Disclosures:
Sebastien J. Hotte
Research Funding (Institution): Astellas, AstraZeneca, Ayala, Bayer, BMS, Eisai, Exelixis, Janssen, Ipsen, Merck, Roche, Sanofi, SeaGen, SignalChem
Grants (Institution): BMS, Janssen, Bayer
Consultant/Honoraria (Self): Astellas, AtraZeneca ,Bayer, BMS, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche, SeaGen
Tamim Nizai
Honoraria/Research fun: Abbvie, Sanofi, TerSera, Knight Therapeutics, AstraZeneca, Bayer, Astellas, Janssen, Merck, Amgen, AAA
Andrea Kokorovic
No disclosures
Disclosures:
Girish Kilkarni
Advisory Boards: Janssen, Merck, Roche, Ferring, Astellas, Theralase
Grants/Honoraria: Abbvie, Sanofi, Ferring, TerSera, Knight Therapeutics, Verity
Clinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, Theralase, Janssen, Pfizer
Krista Noonan
Consulting/Honoraria: AstraZeneca, BMS, Janssen, Merck, Pfizer, EMD Serono
Research Support: Roche
Disclosures:
Girish Kilkarni
Advisory Boards: Janssen, Merck, Roche, Ferring, Astellas, Theralase
Grants/Honoraria: Abbvie, Sanofi, Ferring, TerSera, Knight Therapeutics, Verity
Clinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, Theralase, Janssen, Pfizer
Krista Noonan
Consulting/Honoraria: AstraZeneca, BMS, Janssen, Merck, Pfizer, EMD Serono
Research Support: Roche
Disclosures:
Michael Leveridge
Ipsen - speaker session moderator 2019
Maryam Soleimani
Honorarium: Pfizer
Grant funding: Abbvie, Astellas, Bayer
Himu Lukka
No disclosures
Disclosures:
Sebastien J. Hotte
Research Funding (Institution): Astellas, AstraZeneca, Ayala, Bayer, BMS, Eisai, Exelixis, Janssen, Ipsen, Merck, Roche, Sanofi, SeaGen, SignalChem
Grants (Institution): BMS, Janssen, Bayer
Consultant/Honoraria (Self): Astellas, AtraZeneca ,Bayer, BMS, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche, SeaGen
Tamim Nizai
Honoraria/Research fun: Abbvie, Sanofi, TerSera, Knight Therapeutics, AstraZeneca, Bayer, Astellas, Janssen, Merck, Amgen, AAA
Andrea Kokorovic
No disclosures
Disclosures:
Michael Leveridge
Ipsen - speaker session moderator 2019
Maryam Soleimani
Honorarium: Pfizer
Grant funding: Abbvie, Astellas, Bayer
Himu Lukka
No disclosures
Delay of Injection (Q&A series)
0:00 - Ricardo Rendon
9:30 - Fred Saad
18:10 - Jasper Yuen
Podcast Host Disclosures:
Dr. Alimohamed has had a consulting or advisory role with Astellas Pharma, AstraZeneca, Janssen, Merck, Pfizer, and Sanofi Canada.
Dr. Lalani has received honoraria from Astellas Pharma, Bayer, Bristol-Myers Squibb, Merck, Novartis, Pfizer, Roche/Genentech, and TerSera; has had a consulting or advisory role with Abbvie, Astellas Pharma, Bayer, Bristol-Myers Squibb, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche/Genentech, and TerSera; and has received research funding from Bristol-Myers Squibb (Inst), Ipsen, Novartis, and Roche.
Accreditation:
This podcast was accredited by the Canadian Urological Association in accordance with the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
After completing the self-assessment questions at the link below, listeners are eligible to claim Section 3 self-assessment credits.
Obtain Section 3 Credits Here >
References:
Bellmunt J, et al. Pembrolizumab (pembro) versus investigator’s choice of paclitaxel, docetaxel, or vinflunine in recurrent, advanced urothelial cancer (UC): 5-year follow-up from the phase 3 KEYNOTE-045 trial. J Clin Oncol. 2021;39(suppl 15): abstr 4532. https://bit.ly/3axehzb
Loriot Y, et al. Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma. N Engl J Med. 2019;381(4):338-348. https://www.nejm.org/doi/full/10.1056/NEJMoa1817323
O’Donnell PH, et al. First-line pembrolizumab (pembro) in cisplatin-ineligible patients with advanced urothelial cancer (UC): Response and survival results up to five years from the KEYNOTE-052 phase 2 study. J Clin Oncol. 2021;39(suppl 15): abstr 4508. https://bit.ly/3gyklv5
Powles T, et al. Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma. N Engl J Med. 2020;383(13):1218-1230. https://www.nejm.org/doi/full/10.1056/NEJMoa2002788
Powles T, et al. Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma. N Engl J Med. 2021;384(12):1125-1135. https://www.nejm.org/doi/full/10.1056/NEJMoa2035807
Disclosures:
Daniel Heng
Consultancies and advisory boards: BMS, Merck, Pfizer, Novartis, Eisai, Exilexas, Ipsen
Anand Swaminath
Advisory board: Astrazeneca
Expert Speaker: Astrazeneca, BMS, Eisai
Grants (in kind): BMS, Roche
Rodney Breau
No disclosures
Disclosures:
Daniel Heng
Consultancies and advisory boards: BMS, Merck, Pfizer, Novartis, Eisai, Exilexas, Ipsen
Anand Swaminath
Advisory board: Astrazeneca
Expert Speaker: Astrazeneca, BMS, Eisai
Grants (in kind): BMS, Roche
Rodney Breau
No disclosures
Disclosures:
Fabio Cury
Educational grants: Sanofi S.A., Boston Scientific
Honoraria/Travel Support: Varian Medical Systems, Bayer AG, Abbvie
Neil Fleshner
Payment: Astellas, Janssen, Abbvie, Sanofi, Merck
Grant/Honorarium: Astellas, Janssen, Bayey
Investments: Verity Pharma
Clinical Trials: Astellas, Janssen, Bayer
Leadership position: Point Biopharma
Di (Maria) Jiang
Speaker's honoraria: Ipsen, Janssen, Bayer
Disclosures:
Brita Danielson
Honoraria and speakers fees: Astellas, Amgen, Bayer, Ferring, Janssen
Nazanin Fallah-Rad
Consultancy/Advisory: Merck, Ipsen, Pfizer, Nekktar therapeutics
Honorariums: Bayer, Janssen, Ipsen, Astellas, Pfizer, Merck
Travel Grants: Nekktar Therapeutics
Vincent Fradet
Consultant, speaker or research agreement: Abbvie, Amgen, Astra Zeneca, Astellas, Bayer, Ferring, Janssen, Sanofi
Disclosures:
Fabio Cury
Educational grants: Sanofi S.A., Boston Scientific
Honoraria/Travel Support: Varian Medical Systems, Bayer AG, Abbvie
Neil Fleshner
Payment: Astellas, Janssen, Abbvie, Sanofi, Merck
Grant/Honorarium: Astellas, Janssen, Bayey
Investments: Verity Pharma
Clinical Trials: Astellas, Janssen, Bayer
Leadership position: Point Biopharma
Di (Maria) Jiang
Speaker's honoraria: Ipsen, Janssen, Bayer
Disclosures:
Brita Danielson
Honoraria and speakers fees: Astellas, Amgen, Bayer, Ferring, Janssen
Nazanin Fallah-Rad
Consultancy/Advisory: Merck, Ipsen, Pfizer, Nekktar therapeutics
Honorariums: Bayer, Janssen, Ipsen, Astellas, Pfizer, Merck
Travel Grants: Nekktar Therapeutics
Vincent Fradet
Consultant, speaker or research agreement: Abbvie, Amgen, Astra Zeneca, Astellas, Bayer, Ferring, Janssen, Sanofi
Disclosures:
Jeffrey Campbell
Advisory Board/Grant/Honorarium: Boston Scientific, Abbvie, Paladin Labs
Premal Patel
Advisory Board/Grant/Honorarium: Boston Scientific
Disclosures:
Girish Kilkarni
Advisory Boards: Janssen, Merck, Roche, Ferring, Astellas, Theralase
Grants/Honoraria: Abbvie, Sanofi, Ferring, TerSera
Clinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, Theralase
Ross Mason
Advisory Boards: Astellas, Abbvie, TerSara, Verity
Grants/Honoraria: Abbvie, Sanofi, TerSara, Bladder Cancer Canada
Clinical Trials: Merck, Bayer
Disclosures:
Andrea G. Lantz Powers
none
Ben Chew
Consultant: Bard Medical, Boston Scientific, Cook Medical, Olympus, Poly-Med, Adva-TEC inc., Auris Surgical, Coloplast
Speakers Bureau: Boston Scientific, Cook Medical, Olympus, Coloplast
Grants: Boston Scientific, Cook Medical, Olympus
Clinical Trials: Olympus, Bosotn Scientific, Cook Medical
Disclosures:
Ricardo Rendon
Advisory Board: Astellas, Amgen, Abbvie, Janssen, Bayer, AstraZeneca, Ferring, Sanofi
Speakers Bureau: Astellas, Amgen, Ferring, Janssen
Clinical Trials: Amgen, Astellas, Abbvie, Ferring, Janssen, AstraZeneca, Sanofi, Pfizer, Myovant
Disclosures:
Ashley Cox
Advisory Board: Astellas, Pfizer, Teva
Clinical Trial: Aquinox
Laura Nguyen
Speakers Bureau: Astella, Pfizer
Grant/Honorarium: Ontario College of Family Physicians
The Canadian Urological Association is excited to be launching its new podcast series! Subscribe today to make sure you stay up to date with the latest episodes from CUA – The voice of urology in Canada.
Visit cua.org for more info!
Early vs Delayed Therapy (Q&A Series)
0:00 - Neil Fleshner
3:27 - Martin Gleave
11:52 - Mira Keyes
21:10 - Laurence Klotz
28:40 - Abdenour Nabid
37:10 - Tamim Niazi
44:05 - Fred Saad
49:55 - Bobby Shayegan
Evolution of Landscape (Q&A Series)
0:00 - Neil Fleshner
3:30 - Martin Gleave
11:20 - Mira Keyes
15:40 - Laurence Klotz
20:34 - Abdenour Nabid
26:25 - Tamim Niazi
33:35 - Fred Saad
38:35 - Bobby Shayegan
Low T and Breakthrough (Q&A Series)
0:00 - Neil Fleshner
1:07 - Martin Gleave
4:07 - Mira Keyes
9:00 - Laurence Klotz
12:32 - Abdenour Nabid
16:50 - Tamim Niazi
20:55 - Fred Saad
23:20 - Bobby Shayegan
Intermittent vs Continuous (Q&A Series)
0:00 - Neil Fleshner
2:50 - Martin Gleave
10:30 - Mira Keyes
17:30 - Laurence Klotz
24:30 - Abdenour Nabid
29:35 - Tamim Niazi
35:05 - Fred Saad
40:50 - Bobby Shayegan
Androgen Deprivation Therapy (Q&A series)
0:00 - Mira Keyes
9:53 - Abdenour Nabid
14:55 - Tamim Niazi
Qu'est-ce qui rend l'urologie spéciale? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
Quel est le marché du travail pour les urologues de la prochaine décennie? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
Quelles qualitiés font un grand urologue? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
Que pensez-vous de l'equilibre entre votre vie professionnelle et votre vie privee? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
Y a-t-il un inconvénient à être urologue? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
Pourquoi avez-vous choisi l'urologie comme spécialité? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
Quel est votre conseil pour un étudiant intéressé par l'urologie? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
Où pensez-vous que l'urologie sera dans dix ans? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
Quelle est la meilleure partie d'être un urologue? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
Trouvez-vous que l'urologie donne une carrière enrichissante? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
À quoi ressemble votre horarie hebdomadaire? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
Do you find urology a rewarding career? (What is Urology Series). To view the accompanying video of this audio clip please click here.
What qualities make a great urologist? (What is Urology Series). To view the accompanying video of this audio clip please click here.
Why did you pick urology as a specialty? (What is Urology Series). To view the accompanying video of this audio clip please click here.
What is the best part of being an urologist? (What is Urology Series). To view the accompanying video of this audio clip please click here.
What is urology? (What is Urology Series). To view the accompanying video of this audio clip please click here.
Qu'est-ce que l'urologie? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
What is the job market for urologists in the next decade? (What is Urology Series). To view the accompanying video of this audio clip please click here.
What makes urology special? (What is Urology Series). To view the accompanying video of this audio clip please click here.
Where do you think urology will be in ten years from now? (What is Urology Series). To view the accompanying video of this audio clip please click here.
How do you feel about your work life balance? (What is Urology Series). To view the accompanying video of this audio clip please click here.
Is there a downside to being an urologist? (What is Urology Series). To view the accompanying video of this audio clip please click here.
What is your weekly schedule like? (What is Urology Series). To view the accompanying video of this audio clip please click here.
What is your advice for a student interested in urology? (What is Urology Series). To view the accompanying video of this audio clip please click here.